REG - Oxford Biomedica PLC - BLOCK LISTING RETURN

Oxford BioMedicaAnnouncement

01/07/2024 11:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240701:nRSA6149Ua&default-theme=true

RNS Number : 6149U  Oxford Biomedica PLC  01 July 2024

 Name of applicant:                                                                OXFORD BIOMEDICA PLC
 Name of scheme:                                                                   2015 Employee Share Option Scheme
 Period of return:                        From:                                    1 January 2024  To:           30 June 2024
 Balance of unallotted securities under scheme(s) from previous return:            306,521
 Plus:  The amount by which the block scheme(s) has been increased since the       NIL
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         11,802
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        294,719

 

 

 Name of applicant:                                                                OXFORD BIOMEDICA PLC
 Name of scheme:                                                                   2015 Long Term Incentive Plan
 Period of return:                        From:                                    1 January 2024  To:         30 June 2024
 Balance of unallotted securities under scheme(s) from previous return:            250,368
 Plus:  The amount by which the block scheme(s) has been increased since the       250,000
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         107,069
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        393,299

 

 

 

 Name of applicant:                                                                OXFORD BIOMEDICA PLC
 Name of scheme:                                                                   2015 Deferred Bonus Plan
 Period of return:                        From:                                    1 January 2024  To:        30 June 2024
 Balance of unallotted securities under scheme(s) from previous return:            268,072
 Plus:  The amount by which the block scheme(s) has been increased since the       50,000
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         31,281
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        286,791

 

 

 

 Name of applicant:                                                                OXFORD BIOMEDICA PLC
 Name of scheme:                                                                   Sharesave Scheme
 Period of return:                        From:                                    1 January 2024  To:      30 June 2024
 Balance of unallotted securities under scheme(s) from previous return:            339,753
 Plus:  The amount by which the block scheme(s) has been increased since the       NIL
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         NIL
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        339,753

 

 Name of contact:              Natalie Walter, Company Secretary
 Telephone number of contact:  01865 783000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRRBMMTMTTMBJI